1. Black E, Khor KE, Kennedy D, Chutatape A, Sharma S, Vancaillie T, Demirkol A. Medication Use and Pain Management in Pregnancy: A Critical Review. Pain Pract. 2019 Nov;19(8):875-899
2. Tobon AL, Habecker E, Forray A. Opioid Use in Pregnancy. Curr Psychiatry Rep. 2019 Nov 16;21(12):118. doi: 10.1007/s11920-019-1110-4. PMID: 31734808.
3. Lind JN, Interrante JD, Ailes EC, Gilboa SM, Khan S, Frey MT, Dawson AL, Honein MA, Dowling NF, Razzaghi H, Creanga AA, Broussard CS. Maternal Use of Opioids During Pregnancy and Congenital Malformations: A Systematic Review. Pediatrics. 2017 Jun;139(6):e20164131. doi: 10.1542/peds.2016-4131. PMID: 28562278; PMCID: PMC5561453.
4. Aragao F, Tobias A. Pharmacological treatment of pain in pregnancy. BrJP. 2019 Dec; 2(4).
5. TGA. Prescribing medicines in pregnancy database. 2023. https://www.tga.gov.au/products/medicines/find-information-about-medicine/prescribing-medicines-pregnancy-database
6. Shalini M, Sunali K. Safety of Analgesics in Pregnancy. International Journal of Obstetrics and Gynaecology Research. 2016; 3(1): p. 208-212.
7. Dos Santos CS, Silva PV, Castelo R, Tiago J. Premature closure of ductus arteriosus after a single dose of diclofenac during pregnancy. BMJ Case Rep. 2021 Jun 24;14(6):e243485. doi: 10.1136/bcr-2021-243485. PMID: 34167992; PMCID: PMC8231045.
8. U.S. Food and Drug Administration: FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later because they can result in low amniotic fluid. FDA drug safety. Communication. 2020;2020(10/15):1–9
9. Alemu BK, Wolle NN. Prescription drug use and potential teratogenicity risk among pregnant women attending maternal and child health clinic of Kemisse General Hospital, Northeast, Ethiopia. BMC Res Notes. 2019 Sep 18;12(1):592. doi: 10.1186/s13104-019-4641-1. PMID: 31533806; PMCID: PMC6751805.
10. Cavalli E, Mammana S, Nicoletti F, Bramanti P, Mazzon E. The neuropathic pain: An overview of the current treatment and future therapeutic approaches. Int J Immunopathol Pharmacol. 2019 Jan-Dec;33:2058738419838383. doi: 10.1177/2058738419838383. PMID: 30900486; PMCID: PMC6431761.
11. Alsanie WF, Alhomrani M, Gaber A, Habeeballah H, Alkhatabi HA, Felimban RI, Abdelrahman S, Hauser CAE, Chaudhary AG, Alamri AS, Raafat BM, Alamri A, Anwar S, Alswat KA, Althobaiti YS, Asiri YA. The Effects of Prenatal Exposure to Pregabalin on the Development of Ventral Midbrain Dopaminergic Neurons. Cells. 2022 Mar 1;11(5):852. doi: 10.3390/cells11050852. PMID: 35269474; PMCID: PMC8909856.
12. Bérard A, Zhao JP, Sheehy O. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort. BMJ Open. 2017 Jan 12;7(1):e013372. doi: 10.1136/bmjopen-2016-013372. PMID: 28082367; PMCID: PMC5278249.
13. Dandjinou M, Sheehy O, Bérard A. Antidepressant use during pregnancy and the risk of gestational diabetes mellitus: a nested case-control study. BMJ Open. 2019 Oct 1;9(9):e025908. doi: 10.1136/bmjopen-2018-025908. PMID: 31575566; PMCID: PMC6830475.
14. Shah S, Banh ET, Koury K, Bhatia G, Nandi R, Gulur P. Pain Management in Pregnancy: Multimodal Approaches. Pain Res Treat. 2015;2015:987483. doi: 10.1155/2015/987483. Epub 2015 Sep 13. PMID: 26448875; PMCID: PMC4584042.